Polterauer S[Author] - Search Results

Year	Number of Results
2004	1
2005	1
2007	5
2008	7
2009	6
2010	8
2011	8
2012	9
2013	10
2014	4
2015	12
2016	11
2017	9
2018	8
2019	12
2020	7
2021	9
2022	6

1

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older.

Reiser E, Pötsch N, Seebacher V, Reinthaller A, Wimazal F, Fleischmann E, Krainer M, Horvat R, Polterauer S, Grimm C. Reiser E, et al. Among authors: polterauer s. Arch Gynecol Obstet. 2021 Feb;303(2):557-563. doi: 10.1007/s00404-020-05807-9. Epub 2020 Oct 3. Arch Gynecol Obstet. 2021. PMID: 33009994 Free PMC article.

2

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report.

Paspalj V, Polterauer S, Poetsch N, Reinthaller A, Grimm C, Bartl T. Paspalj V, et al. Among authors: polterauer s. Gynecol Oncol Rep. 2021 Jun 24;37:100817. doi: 10.1016/j.gore.2021.100817. eCollection 2021 Aug. Gynecol Oncol Rep. 2021. PMID: 34258357 Free PMC article.

3

Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.

Petru E, Singer CF, Polterauer S, Galid A, Schauer C, Klocker J, Seifert M, Reinthaller A, Benedicic C, Hubalek M, Hefler L, Marth C, Scholl-Firon T, Bogner G, Zeimet AG. Petru E, et al. Among authors: polterauer s. Wien Med Wochenschr. 2015 Oct;165(19-20):387-94. doi: 10.1007/s10354-015-0392-3. Epub 2015 Oct 15. Wien Med Wochenschr. 2015. PMID: 26471371 Review.

4

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients.

Bartl T, Onoprienko A, Hofstetter G, Müllauer L, Poetsch N, Fuereder T, Kofler P, Polterauer S, Grimm C. Bartl T, et al. Among authors: polterauer s. Biomolecules. 2021 Nov 16;11(11):1700. doi: 10.3390/biom11111700. Biomolecules. 2021. PMID: 34827698 Free PMC article.

5

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data.

Oberndorfer F, Moling S, Hagelkruys LA, Grimm C, Polterauer S, Sturdza A, Aust S, Reinthaller A, Müllauer L, Schwameis R. Oberndorfer F, et al. Among authors: polterauer s. J Pers Med. 2021 Jan 15;11(1):48. doi: 10.3390/jpm11010048. J Pers Med. 2021. PMID: 33467460 Free PMC article.

6

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome.

Bekos C, Pils D, Dekan S, Hofstetter G, Horak P, Reinthaller A, Polterauer S, Schwameis R, Aust S. Bekos C, et al. Among authors: polterauer s. Sci Rep. 2021 Mar 18;11(1):6400. doi: 10.1038/s41598-021-85966-0. Sci Rep. 2021. PMID: 33737722 Free PMC article.

7

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer.

Bekos C, Grimm C, Kranawetter M, Polterauer S, Oberndorfer F, Tan Y, Müllauer L, Singer CF. Bekos C, et al. Among authors: polterauer s. J Pers Med. 2021 Jun 24;11(7):593. doi: 10.3390/jpm11070593. J Pers Med. 2021. PMID: 34202525 Free PMC article.

8

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium.

Obermayr E, Braicu EI, Polterauer S, Loverix L, Concin N, Woelber L, Mahner S, Sehouli J, Van Gorp T, Vergote I, Zeillinger R, Aust S. Obermayr E, et al. Among authors: polterauer s. Cancers (Basel). 2021 Nov 23;13(23):5865. doi: 10.3390/cancers13235865. Cancers (Basel). 2021. PMID: 34884980 Free PMC article.

9

Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study.

Sturdza AE, Pötter R, Kossmeier M, Kirchheiner K, Mahantshetty U, Haie-Meder C, Lindegaard JC, Jurgenliemk-Schulz I, Tan LT, Hoskin P, van Limbergen E, Gillham C, Segedin B, Tharavichitkul E, Iturre EV, Fokdal LU, Polterauer S, Kirisits C, Tanderup K. Sturdza AE, et al. Among authors: polterauer s. Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):168-177. doi: 10.1016/j.ijrobp.2021.04.022. Epub 2021 Apr 29. Int J Radiat Oncol Biol Phys. 2021. PMID: 33932530

10

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.

Bartl T, Bekos C, Postl M, Alexander R, Polterauer S, Stefanie A, Richard S. Bartl T, et al. Among authors: polterauer s. J Gynecol Oncol. 2021 Jan;32(1):e1. doi: 10.3802/jgo.2021.32.e1. Epub 2020 Oct 21. J Gynecol Oncol. 2021. PMID: 33185042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results